Clinical Usefulness of Serum Pepsinogen II in the Management of Helicobacter pylori Infection

By  

Digestion, Vol. 70, Iss. 3, 2005-01 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method

By  

Digestion, Vol. 93, Iss. 1, 2016-0 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais

By Yamada Sirikan   Matsuhisa Takeshi   Makonkawkeyoon Luksana   Chaidatch Suparp   Kato Shunji   Matsukura Norio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1169-1177

Springer Publishing Company

Access to resources Recommend Favorite

Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings

By  

Digestion, Vol. 95, Iss. 4, 2017-06 ,pp. : 314-318

Karger

Access to resources Recommend Favorite

Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study

By Shikata Kentaro   Ninomiya Toshiharu   Yonemoto Koji   Ikeda Fumie   Hata Jun   Doi Yasufumi   Fukuhara Masayo   Matsumoto Takayuki   Iida Mitsuo   Kitazono Takanari   Kiyohara Yutaka  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 6, 2012-06 ,pp. : 669-675

Informa Healthcare

Access to resources Recommend Favorite